Update on Demodex Blepharitis
Christopher Starr, M.D., of Weill Cornell Medical College in New York discusses of the challenges of making a diagnosis and a new treatment.
Weathering the GLP-1 Storm
How health plans and self-insured employers coped with the huge number of prescriptions for weight loss. It started with off-label Ozempic (semaglutide) and now there’s FDA-approved Wegovy (semaglutide) and Zepbound (tirzepatide).
A Conversation with Don Hall, M.P.H.
On public health, Medicaid and Medicaid managed care, and profit seeking in healthcare.
Medical Records Can Be Messy. One Company Says AI Can Bring Clarity
xCures says artificial intelligence and machine learning can help make sense of disparate medical records.
Meet the Superstars of Aging: Centenarians
The number of people living to 100 is growing in the U.S. and around the world. Defying the overall trend of older people having more health issues, they are not major users of healthcare.
mRNA Vaccine Momentum
The success of mRNA vaccines against COVID-19 has led to a surge of mRNA vaccines being developed for other diseases.
